Pharmaceuticals

ERT Achieves Cardiac Safety Milestone after Completing 150th TET Trial

Published in Healthcare Mergers, Acquisitions and Ventures Week, September 19th, 2009

ERT (NASDAQ:ERES) has celebrated a significant milestone by completing its 150th thorough QT clinical Trial (TET). ERT provides full TET support to the biopharmaceutical industry, including consultation, study design, and provision of ECG equipment to ECG analysis, data processing, management, reconciliation, reporting, quality control and regulatory support.

Cardiac safety concerns continue to be the primary reason for drugs being refused licenses or to carry restricted labeling and in the worst cases withdrawn from market completely. As a result, all new drugs are expected to undergo electrocardiographic testing (ECG) in the clinical development process, and with the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2009-09-19)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

1105 Government Information Group
GovSec Announces the 2010 Homeland Security Finance Forum
21st Century Systems, Inc. 21CSI
Purdue University Homeland Security Institute and 21CSI Forge Public-Private Partnership
360networks
360networks Expands Its Coverage Into the Fort Worth, TX Area
5+design
5+design Teams up With Royal Caribbean Cruise Lines to Design Celebrity Equinox
7-Eleven, Inc.
'G.I. Joe: the Rise of Cobra' Advances on 7-Eleven(R) Stores
911 Enable
911 Enable Certifies Its E911 Call Routing Service with Cisco Emergency Responder 7.0
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry